Lentiviral-mediated gene delivery reveals distinct roles of nucleus accumbens dopamine D2 and D3 receptors in novelty- and light-induced locomotor activity

European Journal of Neuroscience

Volumn 35, Issue 8, 2012, Pages 1344-1353

  Fernandes, Alinda R ^a   Easton, Alanna C ^a   De Souza Silva, Maria A ^b   Schumann, Gunter ^a   Müller, Christian P ^a,c   Desrivières, Sylvane ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Behaviour; Dopamine receptor; Lentivirus; Light induced activation; Locomotion; Novelty; Rat; Sensorimotor; ShRNA

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE 2 RECEPTOR GENE; DOPAMINE 3 RECEPTOR GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MAZE TEST; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR GENE; SENSORY STIMULATION;

ANIMALS; CELL LINE, TRANSFORMED; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LENTIVIRUS; LIGHT; MALE; MAZE LEARNING; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; TRANSFECTION;

EID: 84859960632     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2012.08028.x     Document Type: Article

References (87)

1. Accili, D., Fishburn, C.S., Drago, J., Steiner, H., Lachowicz, J.E., Park, B.H., Gauda, E.B., Lee, E.J., Cool, M.H., Sibley, D.R., Gerfen, C.R., Westphal, H. & Fuchs, S. (1996) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA, 93, 1945-1949.
2. Baik, J.H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le Meur, M. & Borrelli, E. (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature, 377, 424-428.
3. Barik, S. & de Beaurepaire, R. (2005) Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 718-726.
4. Black, K.J., Hershey, T., Koller, J.M., Videen, T.O., Mintun, M.A., Price, J.L. & Perlmutter, J.S. (2002) A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc. Natl. Acad. Sci. USA, 99, 17113-17118.
5. Blatter, K. & Schultz, W. (2006) Rewarding properties of visual stimuli. Exp. Brain Res., 168, 541-546.
6. Boulay, D., Depoortere, R., Perrault, G., Borrelli, E. & Sanger, D.J. (1999a) Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Neuropharmacology, 38, 1389-1396.
7. Boulay, D., Depoortere, R., Rostene, W., Perrault, G. & Sanger, D.J. (1999b) Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice. Neuropharmacology, 38, 555-565.
8. Bouthenet, M.L., Souil, E., Martres, M.P., Sokoloff, P., Giros, B. & Schwartz, J.C. (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res., 564, 203-219.
9. Braun, A.R., Laruelle, M. & Mouradian, M.M. (1997) Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications. J. Neural. Transm., 104, 341-362.
10. Bromberg-Martin, E.S., Matsumoto, M. & Hikosaka, O. (2010) Dopamine in motivational control: rewarding, aversive, and alerting. Neuron, 68, 815-834.
11. de Bruin, N.M., Ellenbroek, B.A., van Luijtelaar, E.L., Cools, A.R. & Stevens, K.E. (2001) Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell. Neuroscience, 105, 169-180.
12. Brummelkamp, T.R., Bernards, R. & Agami, R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science, 296, 550-553.
13. Carey, R.J., Huston, J.P. & Müller, C.P. (2008) Pharmacological inhibition of dopamine and serotonin activity blocks spontaneous and cocaine-activated behaviour. Prog. Brain Res., 172, 347-360.
14. Carr, K.D., Yamamoto, N., Omura, M., Cabeza de Vaca, S. & Krahne, L. (2002) Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats. Psychopharmacology (Berl.), 163, 76-84.
15. Chase, D.L., Pepper, J.S. & Koelle, M.R. (2004) Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans. Nat. Neurosci., 7, 1096-1103.
16. Chourbaji, S., Brandwein, C., Vogt, M.A., Dormann, C., Mueller, R., Drescher, K.U., Gross, G. & Gass, P. (2008) Dopamine receptor 3 (D3) knockout mice show regular emotional behaviour. Pharmacol. Res., 58, 302-307.
17. Clifford, J.J. & Waddington, J.L. (1998) Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach. Psychopharmacology (Berl.), 136, 284-290.
18. Delfs, J.M., Schreiber, L. & Kelley, A.E. (1990) Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J. Neurosci., 10, 303-310.
19. Doi, M., Yujnovsky, I., Hirayama, J., Malerba, M., Tirotta, E., Sassone-Corsi, P. & Borrelli, E. (2006) Impaired light masking in dopamine D2 receptor-null mice. Nat. Neurosci., 9, 732-734.
20. Drago, J., Padungchaichot, P., Accili, D. & Fuchs, S. (1998) Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Dev. Neurosci., 20, 188-203.
21. Fink, J.S. & Smith, G.P. (1980) Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats. Brain Res., 199, 359-384.
22. Gong, W., Neill, D.B., Lynn, M. & Justice, J.B. Jr (1999) Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience, 93, 1349-1358.
23. Gyertyan, I. & Saghy, K. (2004) Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011. Behav. Pharmacol., 15, 253-262.
24. Heidbreder, C.A., Gardner, E.L., Xi, Z.X., Thanos, P.K., Mugnaini, M., Hagan, J.J. & Ashby, C.R. Jr (2005) The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res. Brain Res. Rev., 49, 77-105.
25. Horvitz, J.C., Stewart, T. & Jacobs, B.L. (1997) Burst activity of ventral tegmental dopamine neurons is elicited by sensory stimuli in the awake cat. Brain Res., 759, 251-258.
26. Huang, A.C., Shyu, B.C. & Hsiao, S. (2010) Dose-dependent dissociable effects of haloperidol on locomotion, appetitive responses, and consummatory behavior in water-deprived rats. Pharmacol. Biochem. Behav., 95, 285-291.
27. Hughes, R.N. (2007) Neotic preferences in laboratory rodents: issues, assessment and substrates. Neurosci. Biobehav. Rev., 31, 441-464.
28. Ikemoto, S. (2002) Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience, 113, 939-955.
29. Iversen, S.D. & Iversen, L.L. (2007) Dopamine: 50years in perspective. Trends Neurosci., 30, 188-193.
30. Jankiewicz, M., Groner, B. & Desrivières, S. (2006) Mammalian target of rapamycin regulates the growth of mammary epithelial cells through the inhibitor of deoxyribonucleic acid binding Id1 and their functional differentiation through Id2. Mol. Endocrinol., 20, 2369-2381.
31. Joyce, J.N. & Millan, M.J. (2005) Dopamine D3 receptor antagonists as therapeutic agents. Drug Discov. Today, 10, 917-925.
32. Joyce, J.N. & Millan, M.J. (2007) Dopamine D3 receptor agonists for protection and repair in Parkinson's disease. Curr. Opin. Pharmacol., 7, 100-105.
33. Jung, M.Y., Skryabin, B.V., Arai, M., Abbondanzo, S., Fu, D., Brosius, J., Robakis, N.K., Polites, H.G., Pintar, J.E. & Schmauss, C. (1999) Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors. Neuroscience, 91, 911-924.
34. Kalivas, P.W. & Volkow, N.D. (2005) The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry, 162, 1403-1413.
35. Kapur, S. & Mamo, D. (2003) Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 1081-1090.
36. Karasinska, J.M., George, S.R., Cheng, R. & O'Dowd, B.F. (2005) Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation. Eur. J. Neurosci., 22, 1741-1750.
37. Kelly, P.H. & Iversen, S.D. (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol., 40, 45-56.
38. Kling-Petersen, T., Ljung, E., Wollter, L. & Svensson, K. (1995) Effects of the dopamine D3-and autoreceptor preferring antagonist (-)-DS121 on locomotor activity, conditioned place preference and intracranial self-stimulation in the rat. Behav. Pharmacol., 6, 107-115.
39. Koob, G.F. & Le Moal, M. (2008) Addiction and the brain antireward system. Annu. Rev. Psychol., 59, 29-53.
40. Levant, B. (1997) The D3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol. Rev., 49, 231-252.
41. Maggio, R. & Millan, M.J. (2010) Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance. Curr. Opin. Pharmacol., 10, 100-107.
42. Maggio, R., Scarselli, M., Novi, F., Millan, M.J. & Corsini, G.U. (2003) Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole. J. Neurochem., 87, 631-641.
43. Manzanedo, C., Aguilar, M.A. & Minarro, J. (1999) The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice. Psychopharmacology (Berl.), 143, 82-88.
44. Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G.M., Drago, F. & Di Marzo, V. (2009) Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: possible involvement of the endocannabinoid and endovanilloid systems. Neurobiol. Dis., 36, 70-80.
45. Millan, M.J., Seguin, L., Gobert, A., Cussac, D. & Brocco, M. (2004) The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats. Psychopharmacology (Berl.), 174, 341-357.
46. Mogenson, G.J., Jones, D.L. & Yim, C.Y. (1980) From motivation to action: functional interface between the limbic system and the motor system. Prog. Neurobiol., 14, 69-97.
47. de la Mora, M.P., Gallegos-Cari, A., Arizmendi-Garcia, Y., Marcellino, D. & Fuxe, K. (2010) Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog. Neurobiol., 90, 198-216.
48. Müller, C.P., De Souza Silva, M.A. & Huston, J.P. (2007) Double dissociating effects of sensory stimulation and cocaine on serotonin activity in the occipital and temporal cortices. Neuropharmacology, 52, 854-862.
49. Naldini, L., Blomer, U., Gage, F.H., Trono, D. & Verma, I.M. (1996a) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA, 93, 11382-11388.
50. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M. & Trono, D. (1996b) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 272, 263-267.
51. Neve, K.A., Seamans, J.K. & Trantham-Davidson, H. (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res., 24, 165-205.
52. de Oliveira, A.R., Reimer, A.E. & Brandao, M.L. (2006) Dopamine D2 receptor mechanisms in the expression of conditioned fear. Pharmacol. Biochem. Behav., 84, 102-111.
53. Olsen, C.M. & Winder, D.G. (2009) Operant sensation seeking engages similar neural substrates to operant drug seeking in C57 mice. Neuropsychopharmacology, 34, 1685-1694.
54. Osten, P., Dittgen, T. & Licznerski, P. (2006) Lentivirus-based genetic manipulations in neurons in vivo.
55. Ouagazzal, A.M. & Creese, I. (2000) Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion. Pharmacol. Biochem. Behav., 67, 637-645.
56. Paxinos, G. & Watson, C. (2007) The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
57. Pritchard, L.M., Newman, A.H., McNamara, R.K., Logue, A.D., Taylor, B., Welge, J.A., Xu, M., Zhang, J. & Richtand, N.M. (2007) The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotion. Pharmacol. Biochem. Behav., 86, 718-726.
58. Prut, L. & Belzung, C. (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol., 463, 3-33.
59. Pum, M.E., Huston, J.P., De Souza Silva, M.A. & Müller, C.P. (2008) Visual sensory-motor gating by serotonin activation in the medial prefrontal and occipital, but not in the rhinal, cortices in rats. Neuroscience, 153, 361-372.
60. Pum, M.E., Huston, J.P. & Müller, C.P. (2009a) The role of cortical serotonin in anxiety and locomotor activity in Wistar rats. Behav. Neurosci., 123, 449-454.
61. Pum, M.E., Huston, J.P., Müller, C.P. & De Souza Silva, M.A. (2009b) Light-induced activity in the activity box is not aversively motivated and does not show between-trial habituation. Physiol. Behav., 96, 434-439.
62. Ralph, R.J. & Caine, S.B. (2005) Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. J. Pharmacol. Exp. Ther., 312, 733-741.
63. Ramsey, P.H. (1993) Multiple Comparisons of Independent Means. Marcel Dekker, New York.
64. Roberts, C.L., Marx, M.H. & Collier, G. (1958) Light onset and light offset as reinforcers for the albino rat. J. Comp. Physiol. Psychol., 51, 575-579.
65. Sautel, F., Griffon, N., Sokoloff, P., Schwartz, J.C., Launay, C., Simon, P., Costentin, J., Schoenfelder, A., Garrido, F., Mann, A. & Wermuth, C.G. (1995) Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J. Pharmacol. Exp. Ther., 275, 1239-1246.
66. Scarselli, M., Novi, F., Schallmach, E., Lin, R., Baragli, A., Colzi, A., Griffon, N., Corsini, G.U., Sokoloff, P., Levenson, R., Vogel, Z. & Maggio, R. (2001) D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J. Biol. Chem., 276, 30308-30314.
67. Schwarting, R.K. & Huston, J.P. (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol., 50, 275-331.
68. Seeman, P., Schwarz, J., Chen, J.F., Szechtman, H., Perreault, M., McKnight, G.S., Roder, J.C., Quirion, R., Boksa, P., Srivastava, L.K., Yanai, K., Weinshenker, D. & Sumiyoshi, T. (2006) Psychosis pathways converge via D2high dopamine receptors. Synapse, 60, 319-346.
69. Steiner, H., Fuchs, S. & Accili, D. (1997) D3 dopamine receptor-deficient mouse: evidence for reduced anxiety. Physiol. Behav., 63, 137-141.
70. Stuchlik, A., Rehakova, L., Rambousek, L., Svoboda, J. & Vales, K. (2007) Manipulation of D2 receptors with quinpirole and sulpiride affects locomotor activity before spatial behavior of rats in an active place avoidance task. Neurosci. Res., 58, 133-139.
71. Swerdlow, N.R., Braff, D.L., Masten, V.L. & Geyer, M.A. (1990) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl.), 101, 414-420.
72. Swerdlow, N.R., Caine, S.B. & Geyer, M.A. (1992) Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology (Berl.), 108, 189-195.
73. Swerdlow, N.R., Taaid, N., Oostwegel, J.L., Randolph, E. & Geyer, M.A. (1998) Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behav. Pharmacol., 9, 389-396.
74. Swerdlow, N.R., Lelham, S.A., Sutherland Owens, A.N., Chang, W.L., Sassen, S.D. & Talledo, J.A. (2009) Pramipexole effects on startle gating in rats and normal men. Psychopharmacology (Berl.), 205, 689-698.
75. Thiel, C.M., Müller, C.P., Huston, J.P. & Schwarting, R.K. (1999) High versus low reactivity to a novel environment: behavioural, pharmacological and neurochemical assessments. Neuroscience, 93, 243-251.
76. Usiello, A., Baik, J.H., Rouge-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P.V. & Borrelli, E. (2000) Distinct functions of the two isoforms of dopamine D2 receptors. Nature, 408, 199-203.
77. Vafaizadeh, V., Klemmt, P., Brendel, C., Weber, K., Doebele, C., Britt, K., Grez, M., Fehse, B., Desrivières, S. & Groner, B. (2010) Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation. Stem Cells, 28, 928-938.
78. Walf, A.A. & Frye, C.A. (2007) The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc., 2, 322-328.
79. Wan, F.J. & Swerdlow, N.R. (1993) Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats. Psychopharmacology (Berl.), 113, 103-109.
80. Wang, Y., Xu, R., Sasaoka, T., Tonegawa, S., Kung, M.P. & Sankoorikal, E.B. (2000) Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J. Neurosci., 20, 8305-8314.
81. Waters, N., Lagerkvist, S., Lofberg, L., Piercey, M. & Carlsson, A. (1993a) The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study. Eur. J. Pharmacol., 242, 151-163.
82. Waters, N., Svensson, K., Haadsma-Svensson, S.R., Smith, M.W. & Carlsson, A. (1993b) The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J. Neural Transm. Gen. Sect., 94, 11-19.
83. Weber, K., Bartsch, U., Stocking, C. & Fehse, B. (2008) A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. Mol. Ther., 16, 698-706.
84. Wickens, J.R., Horvitz, J.C., Costa, R.M. & Killcross, S. (2007) Dopaminergic mechanisms in actions and habits. J. Neurosci., 27, 8181-8183.
85. Xu, M., Koeltzow, T.E., Santiago, G.T., Moratalla, R., Cooper, D.C., Hu, X.T., White, N.M., Graybiel, A.M., White, F.J. & Tonegawa, S. (1997) Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron, 19, 837-848.
86. Zahm, D.S. (2000) An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci. Biobehav. Rev., 24, 85-105.
87. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. & Trono, D. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol., 15, 871-875.